CEBP Prevention Award Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giovannucci, E.
Right arrow Articles by Hankinson, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giovannucci, E.
Right arrow Articles by Hankinson, S. E.
Cancer Epidemiology Biomarkers & Prevention Vol. 9, 345-349, April 2000
© 2000 American Association for Cancer Research

A Prospective Study of Plasma Insulin-like Growth Factor-1 and Binding Protein-3 and Risk of Colorectal Neoplasia in Women1

Edward Giovannucci2, Michael N. Pollak, Elizabeth A. Platz, Walter C. Willett, Meir J. Stampfer, Noreen Majeed, Graham A. Colditz, Frank E. Speizer and Susan E. Hankinson

Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115 [E. G., W. C. W., M. J. S., G. A. C., F. E. S., S. E. H.]; Departments of Nutrition [E. G., E. A. P., W. C. W., M. J. S.] and Epidemiology [E. G., E. A. P., W. C. W., M. J. S., G. A. C. S. E. H.], Harvard School of Public Health, Boston, Massachusetts 02115; and Cancer Prevention Research Unit, Departments of Medicine and Oncology, Jewish General Hospital and McGill University, Montreal, Quebec, H3T 1E2 Canada [M. N. P., N. M.]

Insulin-like growth factor-1 (IGF-1) is an important mitogen, and IGF binding protein-3 (IGFBP-3) has opposing effects. Acromegalics, who have abnormally elevated levels of IGF-1, are at increased risk of colorectal tumors. Recent studies have found that IGF-1 levels correlate with risk of prostate cancer and colorectal cancer in men, premenopausal breast cancer in women, and lung cancer in men and women. We examined whether prediagnostic plasma levels of IGF-1 and IGFBP-3 influence risk of colorectal cancer and adenoma in women. From 1989 to 1990, a total of 32,826 women from the Nurses’ Health Study provided blood specimens that were archived in liquid nitrogen. During 6 years of follow-up from 1989 to 1994, we documented 79 new cases of colorectal cancer, 90 cases of intermediate/late-stage adenoma (>=1 cm or tubulovillous/villous histology), and 107 cases of early-stage adenoma (<1 cm and tubular histology). After matching controls (2:1 for cancers and 1:1 for adenomas) to cases by age, month of blood draw, fasting status, and indication for endoscopy (for adenoma controls), plasma IGF-1 and IGFBP-3 levels were measured. Controlling for IGFBP-3 level, relative to women in the low tertile of IGF-1, those in the high tertile were at elevated risk of intermediate/late-stage colorectal neoplasia adenoma [multivariate relative risk (RR), 2.78; 95% confidence interval (CI), 0.76–9.76] and cancer (RR, 2.18; 95% CI, 0.94–5.08). Controlling for IGF-1 level, relative to women in the low tertile of IGFBP-3, women in the high tertile of IGFBP-3 were at lower risk of intermediate/late-stage colorectal adenoma (RR, 0.28; 95% CI, 0.09–0.85) and cancer (RR, 0.28; 95% CI, 0.10–0.83). Neither IGF-1 nor IGFBP-3 had any appreciable relation with early-stage adenoma. These analyses indicate that high levels of circulating IGF-1 and particularly low levels of IGFBP-3 are associated independently with an elevated risk of large or tubulovillous/villous colorectal adenoma and cancer.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
J. Sung, Y.-M. Song, D. A. Lawlor, G. D. Smith, and S. Ebrahim
Height and Site-specific Cancer Risk: A Cohort Study of a Korean Adult Population
Am. J. Epidemiol., July 1, 2009; 170(1): 53 - 64.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Yamaza, Y. Miura, K. Akiyama, Y. Bi, W. Sonoyama, S. Gronthos, W. Chen, A. Le, and S. Shi
Mesenchymal stem cell-mediated ectopic hematopoiesis alleviates aging-related phenotype in immunocompromised mice
Blood, March 12, 2009; 113(11): 2595 - 2604.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. S. Sridhar and P. J. Goodwin
Insulin-Insulin-Like Growth Factor Axis and Colon Cancer
J. Clin. Oncol., January 10, 2009; 27(2): 165 - 167.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. S. Fuchs, R. M. Goldberg, D. J. Sargent, J. A. Meyerhardt, B. M. Wolpin, E. M. Green, H. C. Pitot, and M. Pollak
Plasma Insulin-like Growth Factors, Insulin-like Binding Protein-3, and Outcome in Metastatic Colorectal Cancer: Results from Intergroup Trial N9741
Clin. Cancer Res., December 15, 2008; 14(24): 8263 - 8269.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Khoury-Shakour, S. B. Gruber, F. Lejbkowicz, H. S. Rennert, L. Raskin, M. Pinchev, and G. Rennert
Recreational Physical Activity Modifies the Association Between a Common GH1 Polymorphism and Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3314 - 3318.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
V. G. Kaklamani, K. B. Wisinski, M. Sadim, C. Gulden, A. Do, K. Offit, J. A. Baron, H. Ahsan, C. Mantzoros, and B. Pasche
Variants of the Adiponectin (ADIPOQ) and Adiponectin Receptor 1 (ADIPOR1) Genes and Colorectal Cancer Risk
JAMA, October 1, 2008; 300(13): 1523 - 1531.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H-L Wong, W-P Koh, N M Probst-Hensch, D Van den Berg, M C Yu, and S A Ingles
Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach
Gut, August 1, 2008; 57(8): 1090 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Flood, V. Mai, R. Pfeiffer, L. Kahle, C. J. Rosen, E. Lanza, and A. Schatzkin
Serum Concentrations of Insulin-Like Growth Factor and Insulin-Like Growth Factor Binding Protein 3 and Recurrent Colorectal Adenomas
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1493 - 1498.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Bentov, G. Narla, H. Schayek, K. Akita, S. R. Plymate, D. LeRoith, S. L. Friedman, and H. Werner
Insulin-Like Growth Factor-I Regulates Kruppel-Like Factor-6 Gene Expression in a p53-Dependent Manner
Endocrinology, April 1, 2008; 149(4): 1890 - 1897.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. J. Gunter, D. R. Hoover, H. Yu, S. Wassertheil-Smoller, T. E. Rohan, J. E. Manson, B. V. Howard, J. Wylie-Rosett, G. L. Anderson, G. Y.F. Ho, et al.
Insulin, Insulin-like Growth Factor-I, Endogenous Estradiol, and Risk of Colorectal Cancer in Postmenopausal Women
Cancer Res., January 1, 2008; 68(1): 329 - 337.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. H. Siahpush, T. L. Vaughan, J. N. Lampe, R. Freeman, S. Lewis, R. D. Odze, P. L. Blount, K. Ayub, P. S. Rabinovitch, B. J. Reid, et al.
Longitudinal Study of Insulin-like Growth Factor, Insulin-like Growth Factor Binding Protein-3, and their Polymorphisms: Risk of Neoplastic Progression in Barrett's Esophagus
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2387 - 2395.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. E Chiuve, E. L Giovannucci, S. E Hankinson, S. H Zeisel, L. W Dougherty, W. C Willett, and E. B Rimm
The association between betaine and choline intakes and the plasma concentrations of homocysteine in women
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1073 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Haluska, H. M. Shaw, G. N. Batzel, D. Yin, J. R. Molina, L. R. Molife, T. A. Yap, M. L. Roberts, A. Sharma, A. Gualberto, et al.
Phase I Dose Escalation Study of the Anti Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors
Clin. Cancer Res., October 1, 2007; 13(19): 5834 - 5840.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
D. Spentzos, S. A Cannistra, F. Grall, D. A Levine, K. Pillay, T. A Libermann, and C. S Mantzoros
IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer
Endocr. Relat. Cancer, September 1, 2007; 14(3): 781 - 790.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. C Larsson and A. Wolk
Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 556 - 565.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Schaffer, A. Koushik, H. Trottier, E. Duarte-Franco, N. Mansour, J. Arseneau, D. Provencher, L. Gilbert, W. Gotlieb, A. Ferenczy, et al.
Insulin-like Growth Factor-I and Risk of High-Grade Cervical Intraepithelial Neoplasia
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 716 - 722.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. Lin, S. M. Zhang, N. R. Cook, J. E. Manson, J. E. Buring, and I-M. Lee
Oral Contraceptives, Reproductive Factors, and Risk of Colorectal Cancer among Women in a Prospective Cohort Study
Am. J. Epidemiol., April 1, 2007; 165(7): 794 - 801.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Endocr. Rev., February 1, 2007; 28(1): 20 - 47.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Wu, J. Gu, Q. Dong, M. Huang, K.-A. Do, W. K. Hong, and M. R. Spitz
Joint Effect of Mutagen Sensitivity and Insulin-Like Growth Factors in Predicting the Risk of Developing Secondary Primary Tumors and Tumor Recurrence in Patients with Head and Neck Cancer
Clin. Cancer Res., December 1, 2006; 12(23): 7194 - 7201.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. J. Dignam, B. N. Polite, G. Yothers, P. Raich, L. Colangelo, M. J. O'Connell, and N. Wolmark
Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon Cancer.
J Natl Cancer Inst, November 15, 2006; 98(22): 1647 - 1654.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Bhattacharyya, K. Pechhold, H. Shahjee, G. Zappala, C. Elbi, B. Raaka, M. Wiench, J. Hong, and M. M. Rechler
Nonsecreted Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-independent Mechanisms without Being Concentrated in the Nucleus
J. Biol. Chem., August 25, 2006; 281(34): 24588 - 24601.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. A. Meyerhardt, D. Heseltine, D. Niedzwiecki, D. Hollis, L. B. Saltz, R. J. Mayer, J. Thomas, H. Nelson, R. Whittom, A. Hantel, et al.
Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803
J. Clin. Oncol., August 1, 2006; 24(22): 3535 - 3541.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
E. S Schernhammer, J. M Holly, D. J Hunter, M. N Pollak, and S. E Hankinson
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 583 - 592.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A M M Haydon, R J MacInnis, D R English, H Morris, and G G Giles
Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer
Gut, May 1, 2006; 55(5): 689 - 694.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. K. Wei, J. Ma, M. N. Pollak, N. Rifai, C. S. Fuchs, S. E. Hankinson, and E. Giovannucci
C-Peptide, Insulin-like Growth Factor Binding Protein-1, Glycosylated Hemoglobin, and the Risk of Distal Colorectal Adenoma in Women.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 750 - 755.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S Zanardi, D Serrano, A Argusti, M Barile, M Puntoni, and A Decensi
Clinical trials with retinoids for breast cancer chemoprevention.
Endocr. Relat. Cancer, March 1, 2006; 13(1): 51 - 68.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
E E Frezza, M S Wachtel, and M Chiriva-Internati
Influence of obesity on the risk of developing colon cancer
Gut, February 1, 2006; 55(2): 285 - 291.
[Full Text] [PDF]


Home page
Endocr Relat CancerHome page
P J Jenkins, S Khalaf, W Ogunkolade, K McCarthy, T David, R E Hands, D Davies, and S A Bustin
Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis
Endocr. Relat. Cancer, December 1, 2005; 12(4): 891 - 901.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. C. Larsson, N. Orsini, and A. Wolk
Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
J Natl Cancer Inst, November 16, 2005; 97(22): 1679 - 1687.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. K. Wei, E. Giovannucci, C. S. Fuchs, W. C. Willett, and C. S. Mantzoros
Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study
J Natl Cancer Inst, November 16, 2005; 97(22): 1688 - 1694.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. Canzian, J. D. McKay, R. J. Cleveland, L. Dossus, C. Biessy, C. Boillot, S. Rinaldi, M. Llewellyn, V. Chajes, F. Clavel-Chapelon, et al.
Genetic Variation in the Growth Hormone Synthesis Pathway in Relation to Circulating Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Breast Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2316 - 2325.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. O. Keku, P. K. Lund, J. Galanko, J. G. Simmons, J. T. Woosley, and R. S. Sandler
Insulin Resistance, Apoptosis, and Colorectal Adenoma Risk
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2076 - 2081.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. E Chiuve, E. L Giovannucci, S. E Hankinson, D. J Hunter, M. J Stampfer, W. C Willett, and E. B Rimm
Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 155 - 162.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Zhao, M. Berho, J. Nogueras, D. Sands, E. Weiss, S. Wexner, F. M. Giardiello, and M. Cruz-Correa
Positive Correlation of Insulin-Like Growth Factor-II with Proliferating Cell Index in Patients with Colorectal Neoplasia
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1819 - 1822.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. M. Morimoto, P. A. Newcomb, E. White, J. Bigler, and J. D. Potter
Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1394 - 1401.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Meyerhardt, J. A. Sloan, D. J. Sargent, R. M. Goldberg, M. Pollak, R. F. Morton, R. K. Ramanathan, S. K. Williamson, B. P. Findlay, and C. S. Fuchs
Associations between Plasma Insulin-Like Growth Factor Proteins and C-Peptide and Quality of Life in Patients with Metastatic Colorectal Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1402 - 1410.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. M. Morimoto, P. A. Newcomb, E. White, J. Bigler, and J. D. Potter
Insulin-like Growth Factor Polymorphisms and Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1204 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Le Marchand, L. N. Kolonel, B. E. Henderson, and L. R. Wilkens
Association of an Exon 1 Polymorphism in the IGFBP3 Gene with Circulating IGFBP-3 Levels and Colorectal Cancer Risk: The Multiethnic Cohort Study
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1319 - 1321.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. K. Wei, J. Ma, M. N. Pollak, N. Rifai, C. S. Fuchs, S. E. Hankinson, and E. Giovannucci
A Prospective Study of C-Peptide, Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-1, and the Risk of Colorectal Cancer in Women
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 850 - 855.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. A Lavigne, D. J Baer, H. H Wimbrow, P. S Albert, E. D Brown, J. T Judd, W. S Campbell, C. A Giffen, J. F Dorgan, T. J Hartman, et al.
Effects of alcohol on insulin-like growth factor I and insulin-like growth factor binding protein 3 in postmenopausal women
Am. J. Clinical Nutrition, February 1, 2005; 81(2): 503 - 507.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. J. Limburg, K. E. Anderson, T. W. Johnson, D. R. Jacobs Jr., D. Lazovich, C.-P. Hong, K. K. Nicodemus, and A. R. Folsom
Diabetes Mellitus and Subsite-Specific Colorectal Cancer Risks in the Iowa Women's Health Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 133 - 137.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H.-L. Wong, K. DeLellis, N. Probst-Hensch, W.-P. Koh, D. Van Den Berg, H.-P. Lee, M. C. Yu, and S. A. Ingles
A New Single Nucleotide Polymorphism in the Insulin-Like Growth Factor I Regulatory Region Associates with Colorectal Cancer Risk in Singapore Chinese
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 144 - 151.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. W. Voskuil, A. Vrieling, L. J. van't Veer, E. Kampman, and M. A. Rookus
The Insulin-like Growth Factor System in Cancer Prevention: Potential of Dietary Intervention Strategies
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 195 - 203.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Terzolo, G. Reimondo, M. Gasperi, R. Cozzi, R. Pivonello, G. Vitale, A. Scillitani, R. Attanasio, E. Cecconi, F. Daffara, et al.
Colonoscopic Screening and Follow-Up in Patients with Acromegaly: A Multicenter Study in Italy
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 84 - 90.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. DeLellis, S. Rinaldi, R. J. Kaaks, L. N. Kolonel, B. Henderson, and L. Le Marchand
Dietary and Lifestyle Correlates of Plasma Insulin-Like Growth Factor-I (IGF-I) and IGF Binding Protein-3 (IGFBP-3): The Multiethnic Cohort
Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1444 - 1451.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Hoppe, T. Rovenna Udam, L. Lauritzen, C. Molgaard, A. Juul, and K. Fleischer Michaelsen
Animal protein intake, serum insulin-like growth factor I, and growth in healthy 2.5-y-old Danish children
Am. J. Clinical Nutrition, August 1, 2004; 80(2): 447 - 452.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Wu, H. Zhao, K.-A. Do, M. M. Johnson, Q. Dong, W. K. Hong, and M. R. Spitz
Serum Levels of Insulin Growth Factor (IGF-I) and IGF-Binding Protein Predict Risk of Second Primary Tumors in Patients with Head and Neck Cancer
Clin. Cancer Res., June 15, 2004; 10(12): 3988 - 3995.
[Abstract] [Full Text] [PDF]


Home page
aacrmtgHome page
E. Giovannucci
Obesity, insulin, and colon cancer.
AACR Meeting Abstracts, March 1, 2004; 2004(1): 1319 - 1320.
[Abstract]


Home page
JCOHome page
J. A. Meyerhardt, J. E. Tepper, D. Niedzwiecki, D. R. Hollis, A. D. McCollum, D. Brady, M. J. O'Connell, R. J. Mayer, B. Cummings, C. Willett, et al.
Impact of Body Mass Index on Outcomes and Treatment-Related Toxicity in Patients With Stage II and III Rectal Cancer: Findings From Intergroup Trial 0114
J. Clin. Oncol., February 15, 2004; 22(4): 648 - 657.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Decensi, U. Veronesi, R. Miceli, H. Johansson, L. Mariani, T. Camerini, M. G. Di Mauro, E. Cavadini, G. De Palo, A. Costa, et al.
Relationships between Plasma Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 and Second Breast Cancer Risk in a Prevention Trial of Fenretinide
Clin. Cancer Res., October 15, 2003; 9(13): 4722 - 4729.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. M. Y. Nomura, G. N. Stemmermann, J. Lee, and M. N. Pollak
Serum Insulin-like Growth Factor I and Subsequent Risk of Colorectal Cancer among Japanese-American Men
Am. J. Epidemiol., September 1, 2003; 158(5): 424 - 431.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. M. Probst-Hensch, H. Wang, V. H. H. Goh, A. Seow, H.-P. Lee, and M. C. Yu
Determinants of Circulating Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations in a Cohort of Singapore Men and Women
Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 739 - 746.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. J. Kim, I.-J. Kang, H. J. Cho, W. K. Kim, Y.-L. Ha, and J. H. Y. Park
Conjugated Linoleic Acid Downregulates Insulin-Like Growth Factor-I Receptor Levels in HT-29 Human Colon Cancer Cells
J. Nutr., August 1, 2003; 133(8): 2675 - 2681.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
B. S. Kristal and U. Paolucci
Caloric Restriction in trans
Sci. Aging Knowl. Environ., July 9, 2003; 2003(27): pe19 - 19.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. H. Saydah, E. A. Platz, N. Rifai, M. N. Pollak, F. L. Brancati, and K. J. Helzlsouer
Association of Markers of Insulin and Glucose Control with Subsequent Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 412 - 418.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. G. Skinner, D. S. Michaud, G. A. Colditz, E. L. Giovannucci, M. J. Stampfer, W. C. Willett, and C. S. Fuchs
Parity, Reproductive Factors, and the Risk of Pancreatic Cancer in Women
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 433 - 438.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. Komninou, A. Ayonote, J. P. Richie Jr., and B. Rigas
Insulin Resistance and Its Contribution to Colon Carcinogenesis
Experimental Biology and Medicine, April 1, 2003; 228(4): 396 - 405.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. A. Meyerhardt, P. J. Catalano, D. G. Haller, R. J. Mayer, J. S. Macdonald, A. B. Benson III, and C. S. Fuchs
Impact of Diabetes Mellitus on Outcomes in Patients With Colon Cancer
J. Clin. Oncol., February 1, 2003; 21(3): 433 - 440.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
P. Boyle and M. E. Leon
Epidemiology of colorectal cancer
Br. Med. Bull., December 1, 2002; 64(1): 1 - 25.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. M. Firth and R. C. Baxter
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Endocr. Rev., December 1, 2002; 23(6): 824 - 854.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. H. Schmitz, R. L. Ahmed, and D. Yee
Effects of a 9-Month Strength Training Intervention on Insulin, Insulin-like Growth Factor (IGF)-I, IGF-binding Protein (IGFBP)-1, and IGFBP-3 in 30-50-Year-Old Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1597 - 1604.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Standal, M. Borset, S. Lenhoff, F. Wisloff, B. Stordal, A. Sundan, A. Waage, and C. Seidel
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor
Blood, December 1, 2002; 100(12): 3925 - 3929.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. R. Spitz, M. J. Barnett, G. E. Goodman, M. D. Thornquist, X. Wu, and M. Pollak
Serum Insulin-like Growth Factor (IGF) and IGF-binding Protein Levels and Risk of Lung Cancer: A Case-Control Study Nested in the {beta}-Carotene and Retinol Efficacy Trial Cohort
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1413 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Giovannucci, C. A. Haiman, E. A. Platz, S. E. Hankinson, M. N. Pollak, and D. J. Hunter
Dinucleotide Repeat in the Insulin-like Growth Factor-I Gene Is Not Related to Risk of Colorectal Adenoma
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1509 - 1510.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. D. Holmes, M. N. Pollak, W. C. Willett, and S. E. Hankinson
Dietary Correlates of Plasma Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 852 - 861.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. D. Holmes, M. N. Pollak, and S. E. Hankinson
Lifestyle Correlates of Plasma Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 862 - 867.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. S. Sandhu, R. Luben, N. E. Day, and K.-T. Khaw
Self-Reported Birth Weight and Subsequent Risk of Colorectal Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 935 - 938.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. Teramukai, T. Rohan, H. Eguchi, T. Oda, K. Shinchi, and S. Kono
Anthropometric and Behavioral Correlates of Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 in Middle-aged Japanese Men
Am. J. Epidemiol., August 15, 2002; 156(4): 344 - 348.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Chang, X. Wu, H. Yu, and M. R. Spitz
Plasma Concentrations of Insulin-like Growth Factors among Healthy Adult Men and Postmenopausal Women: Associations with Body Composition, Lifestyle, and Reproductive Factors
Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 758 - 766.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. S. Sandhu, D. B. Dunger, and E. L. Giovannucci
Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal Cancer
J Natl Cancer Inst, July 3, 2002; 94(13): 972 - 980.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Lucidi, N. Parlanti, F. Piccioni, F. Santeusanio, and P. de Feo
Short-Term Treatment with Low Doses of Recombinant Human GH Stimulates Lipolysis in Visceral Obese Men
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3105 - 3109.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. E. Schoen, J. Schragin, J. L. Weissfeld, F. L. Thaete, R. W. Evans, C. J. Rosen, and L. H. Kuller
Lack of Association between Adipose Tissue Distribution and IGF-1 and IGFBP-3 in Men and Women
Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 581 - 586.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. J. London, J.-M. Yuan, G. S. Travlos, Y.-T. Gao, R. E. Wilson, R. K. Ross, and M. C. Yu
Insulin-Like Growth Factor I, IGF-Binding Protein 3, and Lung Cancer Risk in a Prospective Study of Men in China
J Natl Cancer Inst, May 15, 2002; 94(10): 749 - 754.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R Palmqvist, G Hallmans, S Rinaldi, C Biessy, R Stenling, E Riboli, and R Kaaks
Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden
Gut, May 1, 2002; 50(5): 642 - 646.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
C. S. Carter, M. M. Ramsey, R. L. Ingram, A. B. Cashion, W. T. Cefalu, Z.Q. Wang, and W. E. Sonntag
Models of Growth Hormone and IGF-1 Deficiency: Applications to Studies of Aging Processes and Life-Span Determination
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2002; 57(5): B177 - 188.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
L. Le Marchand, T. Donlon, A. Seifried, R. Kaaks, S. Rinaldi, and L. R. Wilkens
Association of a Common Polymorphism in the Human GH1 Gene with Colorectal Neoplasia
J Natl Cancer Inst, March 20, 2002; 94(6): 454 - 460.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. J. Borugian, S. B. Sheps, A. S. Whittemore, A. H. Wu, J. D. Potter, and R. P. Gallagher
Carbohydrates and Colorectal Cancer Risk among Chinese in North America
Cancer Epidemiol. Biomarkers Prev., February 1, 2002; 11(2): 187 - 193.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. Giovannucci
Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
J. Nutr., November 1, 2001; 131(11): 3109S - 3120.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Decensi, H. Johansson, R. Miceli, L. Mariani, T. Camerini, E. Cavadini, M. G. Di Mauro, A. Barreca, A. G. Gonzaga, S. Diani, et al.
Long-Term Effects of Fenretinide, a Retinoic Acid Derivative, on the Insulin-like Growth Factor System in Women with Early Breast Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1047 - 1053.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Ma, E. Giovannucci, M. Pollak, J. M. Chan, J. M. Gaziano, W. Willett, and M. J. Stampfer
Milk Intake, Circulating Levels of Insulin-Like Growth Factor-I, and Risk of Colorectal Cancer in Men
J Natl Cancer Inst, September 5, 2001; 93(17): 1330 - 1336.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Deal, J. Ma, F. Wilkin, J. Paquette, F. Rozen, B. Ge, T. Hudson, M. Stampfer, and M. Pollak
Novel Promoter Polymorphism in Insulin-Like Growth Factor-Binding Protein-3: Correlation with Serum Levels and Interaction with Known Regulators
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1274 - 1280.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
J. Ma, M. Stampfer, and M. Pollak
RESPONSE: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3
J Natl Cancer Inst, December 6, 2000; 92(23): 1949 - 1949.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. G. Renehan, S. T. O'Dwyer, and S. M. Shalet
RESPONSE: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3
J Natl Cancer Inst, December 6, 2000; 92(23): 1949a - 1949a.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.